PMVP·69353Y103·US·equity·Healthcare - Biotechnology-Activist
PMVP (PMV PHARMACEUTICALS INC) is held by 35 institutional investors as of Q1 2026. Largest holders: TWO SIGMA INVESTMENTS, LP ($2.3M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($2.3M), BlackRock, Inc. ($1.1M). Net institutional sentiment: Mixed.
See how PMVP's score breaks down across 4 SEC sources
Showing 1-20 of 38
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer